Literature DB >> 34750764

Targeting Cyclic Guanylate Monophosphate in Resistant Hypertension and Heart Failure: Are Sacubitril/Valsartan and Vericiguat Synergistic and Effective in Both Conditions?

Giovanna Gallo1, Speranza Rubattu1, Massimo Volpe2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34750764     DOI: 10.1007/s40292-021-00489-z

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


× No keyword cloud information.
  3 in total

Review 1.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

Review 2.  The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction.

Authors:  Stephen J Greene; Mihai Gheorghiade; Barry A Borlaug; Burkert Pieske; Muthiah Vaduganathan; John C Burnett; Lothar Roessig; Johannes-Peter Stasch; Scott D Solomon; Walter J Paulus; Javed Butler
Journal:  J Am Heart Assoc       Date:  2013-12-11       Impact factor: 5.501

3.  An Outbreak of Covid-19 on an Aircraft Carrier.

Authors:  Matthew R Kasper; Jesse R Geibe; Christine L Sears; Asha J Riegodedios; Tina Luse; Annette M Von Thun; Michael B McGinnis; Niels Olson; Daniel Houskamp; Robert Fenequito; Timothy H Burgess; Adam W Armstrong; Gerald DeLong; Robert J Hawkins; Bruce L Gillingham
Journal:  N Engl J Med       Date:  2020-11-11       Impact factor: 91.245

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.